Selective antagonism at dopamine D3 receptors prevents nicotine-triggered relapse to nicotine-seeking behavior

Neuropsychopharmacology

Volumn 28, Issue 7, 2003, Pages 1272-1280

  Andreoli, Michela ^a   Tessari, Michela ^a   Pilla, Maria ^a   Valerio, Enzo ^a   Hagan, Jim J ^a   Heidbreder, Christian A ^a  

^a GSK   (Italy)

Author keywords

Dopamine receptors; Drug dependence; Nicotine; Relapse; Self administration

Indexed keywords

DOPAMINE 3 RECEPTOR BLOCKING AGENT; NICOTINE; SB 277011 A; UNCLASSIFIED DRUG; DOPAMINE RECEPTOR BLOCKING AGENT; N [4 [2 (6 CYANO 1,2,3,4 TETRAHYDRO 2 ISOQUINOLINYL)ETHYL]CYCLOHEXYL] 4 QUINOLINECARBOXAMIDE; NICOTINIC AGENT; NITRILE; QUINOLINE DERIVATIVE; TETRAHYDROISOQUINOLINE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG EFFECT; DRUG SELF ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; RELAPSE; ADDICTION; ANIMAL; ANIMAL BEHAVIOR; ASSOCIATION; COMPARATIVE STUDY; DOSE RESPONSE; FOOD; MALE; PSYCHOLOGICAL ASPECT; RANDOMIZATION; RECURRENT DISEASE; REINFORCEMENT; TIME; WISTAR RAT;

ANIMALS; BEHAVIOR, ANIMAL; CUES; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FOOD; MALE; NICOTINE; NICOTINIC AGONISTS; NITRILES; QUINOLINES; RANDOM ALLOCATION; RATS; RATS, WISTAR; RECURRENCE; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION; SUBSTANCE-RELATED DISORDERS; TETRAHYDROISOQUINOLINES; TIME FACTORS;

EID: 0041421001     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300183     Document Type: Article

References (92)

1. Alleweireldt AT, Weber SM, Kirschner KF, Bullock BL, Neisewander JL (2002). Blockade or stimulation of D1 dopamine receptors attenuates cue reinstatement of extinguished cocaine-seeking behavior in rats. Psychopharmacology (Berl) 159: 284-293.
2. Ashby Jr CR, Minabe Y, Stemp G, Hagan JJ, Middlemiss DN (2000). Acute and chronic administration of the selective D(3) receptor antagonist SB-277011-A alters activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study. J Pharmacol Exp Ther 294: 1166-1174.
3. 3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194. J Pharmacol Exp Ther 287: 187-197.
4. Austin NE, Baldwin , Cutler L, Deeks N, Kelly PJ, Nash M et al (2001). Pharmacokinetics of the novel, high-affinity and selective dopamine D3 receptor antagonist SB-277011 in rat, dog and monkey: in vitro/in vivo correlation and the role of aldehyde oxidase. Xenobiotica 31: 677-686.
5. Balfour DJ, Wright AE, Benwell ME, Birrell CE (2000). The putative role of extra-synaptic mesolimbic dopamine in the neurobiology of nicotine dependence. Behav Brain Res 113: 73-83.
6. Beardsley PM, Sokoloff P, Balster RL, Schwartz JC (2001). The D3R partial agonist, BP897, attenuates the discriminative stimulus effects of cocaine and D-amphetamine and is not self-administered. Behav Pharmacol 12: 1-11.
7. Berridge KC, Robinson TE (1998). What is the role of dopamine in reward: hedonic impact, reward learning or incentive salience. Brain Res Rev 28: 309-369.
8. 2 receptor mRNA. Brain Res 564: 203-219.
9. Brauer LH, Cramblett MJ, Paxton DA, Rose JE (2001). Halperidol reduces smoking of both nicotine-containing and denicotinized cigarettes. Psychopharmacology 159: 31-37.
10. Caggiula AR, Donny EC, White AR, Chaudhri N, Booth S, Gharib MA et al (2001). Cue dependency of nicotine self-administration and smoking. Pharmacol Biochem Behav 70: 515-530.
11. Caine SB, Koob GF, Parsons LH, Everitt BJ, Schwartz JC, Sokoloff P (1997). D3 receptor test in vitro predicts decreased cocaine self-administration in rats. NeuroReport 8: 2373-2377.
12. Caine SB, Negus SS, Mello NK, Patel S, Bristow L, Kulagowski J et al (2002). Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists. J Neurosci 22: 2977-2988.
13. Caskey NH, Jarvik ME, Wirshing WC (1999). The effects of dopaminergic D2 stimulation and blockade on smoking behavior. Exp Clin Psychopharmacol 7: 72-78.
14. Caskey NH, Jarvik ME, Wirshing WC, Madsen DC, Iwanoto-Schaap PN, Eisenberger NI et al (2002). Modulating tobacco smoking rates by dopaminergic stimulation and blockade. Nicotine Tob Res 4: 259-266.
15. Chiamulera C, Rezzaghi F, Ardizzon M, Motta C, Marcon C, Tessari MA (1998). A novel model to study relapse to nicotine-seeking behaviour in rats. Arch Pharmacol 358: R578.
16. Childress AR, Mozley PD, McElgin W, Fitzgerald J, Reivich M, O'Brien CP (1999). Limbic activation during cue-induced cocaine craving. Am J Psychiatry 156: 11-18.
17. Cornish JL, Kalivas PW (2000). Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction. J Neurosci 20: RC89.
18. Corrigall WA, Coen KM (1991a). Cocaine self-administration is increased by both D1 and D2 dopamine antagonists. Pharmacol Biochem Behav 39: 799-802.
19. Corrigall WA, Coen KM (1991b). Selective dopamine antagonists reduce nicotine self-administration. Psychopharmacology (Berl) 104: 171-176.
20. Corrigall WA, Coen KM, Zhang J, Adamson KL (2002). Pharmacological manipulations of the pedunculopontine tegmental nucleus in the rat reduce self-adminitration of both nicotine and cocaine. Psychopharmacology 160: 198-205.
21. Dawe S, Gerada C, Russell MA, Gray JA (1995). Nicotine intake in smokers increases following a single dose of haloperidol. Psychopharmacology (Berl) 117: 110-115.
22. Deroche-Gamonet V, Piat F, Le Moal M, Piazza PV (2002). Influence of cue-conditioning on acquisition, maintenance and relapse of cocaine intravenous self-administration. Eur J Neurosci 15: 1363-1370.
23. 3 receptor in the rat brain. Neuroscience 65: 731-745.
24. Diaz J, Pilon C, Le Foll B, Gros C, Triller A, Schwartz JC et al (2000). Dopamine D3 receptors expressed by all mesencephalic dopamine neurons. J Neurosci 20: 8677-8684.
25. Di Chiara G, Imperato A (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85: 5274-5278.
26. Di Chiara G (1995). The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend 28: 95-137.
27. Di Ciano P, Blaha CD, Phillips AG (2001). Changes in dopamine efflux associated with extinction, CS-induced and D-amphetamine-induced reinstatement of drug-seeking behaviour by rats. Behav Brain Res 120: 147-158.
28. 3 dopamine receptor antagonist SB-277011-A. Neuropsychopharmacology 28: 329-338.
29. Ding DCD, Gabbott PLA, Totterdell S (2001). Differences in the laminar origin of projections from the medial prefrontal cortex to the nucleus accumbens shell and core regions in the rat. Brain Res 917: 81-89.
30. Ettenberg A (1990). Haloperidol prevents the reinstatement of amphetamine-rewarded runway responding in rats. Pharmacol Biochem Behav 36: 635-638.
31. Everitt BJ, Parkinson JA, Olmstead MC, Arroyo M, Robledo P, Robbins TW (1999). Associative processes in addiction and reward: the role of amygdala-ventral striatal subsystems. Ann NY Acad Sci 877: 412-438.
32. Fagerstrom KO, Schneider NG (1989). Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med 12: 159-182.
33. Gallistel CR, Davis AJ (1983). Affinity for the dopamine D2 receptor predicts neuroleptic potency in blocking the reinforcing effect of MFB stimulation. Pharmacol Biochem Behav 19: 867-872.
34. Gessa GL, Devoto P, Diana M, Flore G, Melis M, Pistis M (2000). Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex. Neuropsychopharmacology 22: 642-649.
35. Goeders NE, Clampitt DM (2002). Potential role for the hypothalamus-pituitary-adrenal axis in the conditioned reinforcer-induced reinstatement of extinguished cocaine seeking in rats. Psychopharmacology 161: 222-232.
36. Grant S, London ED, Newlin DB, Villemagne VL, Xiang L, Contoreggi C et al (1996). Activation of memory circuits during cue-elicited cocaine craving. Proc Natl Acad Sci USA 93: 12040-12045.
37. 2 receptor expressing neurons. Neuropsychopharmacology 20: 60-80.
38. Gyertyan I, Gal K (2003). Dopamine D3 receptor ligands show place conditioning effect but do not influence cocaine-induced place preference. NeuroReport 14: 93-98.
39. Haile CN, Kosten TA (2001). Differential effects of D1- and D2-like compounds on cocaine self-administration in Lewis and Fischer 344 inbred rats. J Pharmacol Exp Ther 299: 509-518.
40. 3-dopamine receptor agonist (+)-[3H]PD128,907. Psychopharmacology 128: 240-247.
41. Hammer RP, Pires WS, Markou A, Koob GF (1993). Withdrawal following cocaine self-administration decreases regional cerebral metabolic rate in critical brain reward regions. Synapse 14: 73-80.
42. Highfield DA, Mead AN, Grimm JW, Rocha BA, Shaham Y (2002). Reinstatement of cocaine seeking in 129X1/SvJ mice: effects of cocaine cues and food deprivation. Psychopharmacology 161: 417-423.
43. Hummel M, Unterwald EM (2002). D1 dopamine receptor: a putative neurochemical and behavioral link to cocaine action. J Cell Physiol 191: 17-27.
44. Ito R, Robbins TW, Everitt BJ (2001). Dissociation in the effects of lesions of the nucleus accumbems core and shell on the acquisition of a second-order schedule of cocaine reinforcement. Soc Neurosci Abstr 27: 443.9.
45. Jarvik ME, Caskey NH, Wirshing WC, Madsen DC, Iwanoto-Schaap PN, Elins JL et al (2000). Bromocriptine reduces cigarette smoking. Addiction 95: 1173-1183.
46. Khroyan TV, Barrett-Larimore RL, Rowlett JK, Spealman RD (2000). Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists. J Pharmacol Exp Ther 294: 680-687.
47. Kling-Petersen T, Ljung E, Svensson K (1994). The preferential dopamine autoreceptor antagonist (+)-UH232 antagonizes the positive reinforcing effects of cocaine and d-amphetamine in the ICSS paradigm. Pharmacol Biochem Behav 49: 345-351.
48. Koob GF, Le Moal M (1998). Drug abuse: hedonic homeostatic dystregulation. Science 278: 52-58.
49. 3 receptors enhances monoaminergic and cholinergic neurotransmission in the rat anterior cingulate cortex. Neuropsychopharmacology, in press.
50. 3 receptor mRNA and binding sites in human brain. Brain Res Mol Brain Res 18: 187-192.
51. 3 receptor expression accompanying behavioural sensitization to nicotine in rats. Synapse 47: 176-183.
52. Le Foll B, Frances H, Diaz J, Schwartz J-C, Sokoloff P (2002). Role of the dopamine D3 receptor in reactivity to cocaine-associated cues in mice. Eur J Neurosci 15: 2016-2026.
53. Mash DC, Staley JK (1999). D3 dopamine and kappa opioid receptor alterations in human brain of cocaine-overdose victims. Ann NY Acad Sci 877: 507-522.
54. McEvoy JP, Freudenreich O, Levin ED, Rose JE (1995). Haloperidol increases smoking in patients with schizophrenia. Psychopharmacology (Berl) 119: 124-126.
55. McFarland K, Kalivas PW (2001). The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 21: 8655-8663.
56. Miliaressis E, Malette J, Coulombe D (1986a). The effects of pimozide on the reinforcing efficacy of central gray stimulation in the rat. Behav Brain Res 21: 95-100.
57. Miliaressis E, Rompre PP, Laviolette P, Philippe L, Coulombe D (1986b). The curve-shift paradigm in self-stimulation. Physiol Behav 37: 85-93.
58. Murphy MF, Hey K, Johnstone E, Munafo M, Walton R, Willis B et al (2002). Bromocriptine use is associated with decreased smoking rates. Addict Biol 7: 325-328.
59. 2 receptors to mesostriatal regions of human forebrain. Proc Natl Acad Sci USA 91: 11271-11275.
60. Nakajima S, Patterson RL (1997). The involvement of dopamine D2 receptors, but not D3 or D4 receptors, in the rewarding effect of brain stimulation in the rat. Brain Res 760: 74-79.
61. Neisewander JL, Baker DA, Fuchs RA, Tran-Nguyen LT, Palmer A, Marshall JF (2000). Fos protein expression and cocaine-seeking behavior in rats after exposure to a cocaine self-administration environment. J Neurosci 20: 798-805.
62. Neisewander JL, O'Dell LE, Tran-Nguyen LT, Castadena E, Fuchs RA (1996). Dopamine overflow in the nucleus accumbens during extinction and reinstatement of cocaine self-administration behavior. Neuropsychopharmacology 15: 506-514.
63. Norman AB, Norman MK, Hall JF, Tsibulsky VL (1999). Priming threshold: a novel quantitative measure of the reinstatement of cocaine self-administration. Brain Res 831: 165-174.
64. O'Brien CP, Childress AR, Ehrman RN, Robbins SJ (1998). Conditioning factors in drug abuse: can they explain compulsion? J Psychopharmacol 12: 15-22.
65. Parsons LH, Caine SB, Sokoloff P, Schwartz JC, Koob GF, Weiss F (1996). Neurochemical evidence that postsynaptic nucleus accumbens D3 receptor stimulation enhances cocaine reinforcement. J Neurochem 67: 1078-1089.
66. Paterson NE, Markou A (2002). Increased GABA neurotransmission via administration of gamma-vinyl GABA decreased nicotine self-administration in the rat. Synapse 44: 252-253.
67. 3 receptor agonist. Nature (Lond) 400: 371-375.
68. 3 receptor antagonist, SB-277011-A. J Pharmacol Exp Ther 294: 1154-1165.
69. Sautel F, Griffon N, Sokoloff P, Schwartz JC, Launay C, Simon P et al (1995). Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents. J Pharmacol Exp Ther 275: 1239-1246.
70. Schenk S, Partridge B (1999). Cocaine-seeking produced by experimenter-administered drug injections: dose-effect relationships in rats. Psychopharmacology (Berl) 147: 285-290.
71. Segal DM, Moraes CT, Mash DC (1997). Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities. Brain Res Mol Brain Res 45: 335-339.
72. Self DW, Barnhart WJ, Lehman DA, Nestler EJ (1996). Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists. Science (Wash, DC) 271: 1586-1589.
73. Self DW, Genova LM, Hope BT, Barnhart WJ, Spencer JJ, Nestler EJ (1998). Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior. J Neurosci 18: 1848-1859.
74. Self DW, Karanian DA, Spencer JJ (2000). Effects of the novel D1 dopamine receptor agonist ABT-431 on cocaine self-administration and reinstatement. Ann NY Acad Sci 909: 133-144.
75. 3 dopamine receptor in cellular and organismal function. Psychopharmacology 135: 1-16.
76. Shoaib M, Stolerman IP (1999). Plasma nicotine and cotinine levels following intravenous nicotine self-administration in rats. Psychopharmacology 143: 318-321.
77. Smart D, Wood MD (2000). Cytosensor techniques for examining signal transduction of neurohormones. Biochem Cell Biol 78: 281-288.
78. 3) as a target for neuroleptics. Nature 347: 146-151.
79. Spealman RD (1996). Dopamine D3 receptor agonists partially reproduce the discriminative stimulus effects of cocaine in squirrel monkeys. J Pharmacol Exp Ther 278: 1128-1137.
80. 3 dopamine receptors in the brain reward circuits of human cocaine fatalities. J Neurosci 16: 6100-6106.
81. Stellar JR, Kelly A, Corbett D (1983). Effects of peripheral and central dopamine blockade on lateral hypothalamic stimulation reward: evidence for both reward and motor deficits. Pharmacol Biochem Behav 18: 433-442.
82. 3 receptor antagonist with high oral bioavailability and CNS penetration in the rat. J Med Chem 43: 1878-1885.
83. 3 dopamine receptor mRNA is widely expressed in the human brain. Brain Res 779: 58-74.
84. Tran-Nguyen TL, Baker DA, Grote KA, Solano J, Neisewander JL (1998). Serotonin depletion attenuates cocaine-seeking behavior in rats. Psychopharmacology 146: 60-66.
85. Vorel SR, Ashby Jr CR, Paul M, Liu X, Hayes R, Hagan JJ et al (2002). Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. J Neurosci 22: 9595-9603.
86. 3 receptor antagonists in regard to dopamine release, in vivo receptor displacement and behaviour. J Neural Transm Gen Sect 98: 39-55.
87. Waters N, Svensson K, Haadsma-Svensson SR, Smith MW, Carlsson A (1993). The dopamine D3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity. J Neural Transm 94: 11-19.
88. Weissenborn R, Robbins TW, Everitt BJ (1997). Effects of medial prefrontal or anterior cingulate cortex lesions on responding for cocaine under fixed-ratio and second-order schedules of reinforcement in rats. Psychopharmacology 134: 242-257.
89. Whitelaw RB, Markou A, Robbins TW, Everitt BJ (1996). Excitotoxic lesions of the basolateral amygdala impair the acquisition of cocaine-seeking behaviour under a second-order schedule of reinforcement. Psychopharmacology 127: 213-224.
90. Wise RA, Rompre P-P (1989). Brain dopamine and reward. Annu Rev Psychol 40: 191-225.
91. Wood MD, Boyfield I, Nash DJ, Jewitt FR, Avenell KY, Riley GJ (2000). Evidence for antagonist activity of the dopamine D3 receptor partial agonist, BP 897, at human dopamine D3 receptor. Eur J Pharmacol 407: 47-51.
92. Xu M, Koeltzow TE, Cooper DC, Tonegawa S, White FJ (1999). Dopamine D3 receptor mutant mice exhibit identical responses to putative D3 receptor-selective agonists and antagonists. Synapse 31: 210-215.